Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 2
1994 1
1995 2
1996 2
1997 2
2000 1
2002 1
2003 2
2004 1
2007 1
2014 1
2015 2
2017 2
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
TGF-β2 silencing to target biliary-derived liver diseases.
Dropmann A, Dooley S, Dewidar B, Hammad S, Dediulia T, Werle J, Hartwig V, Ghafoory S, Woelfl S, Korhonen H, Janicot M, Wosikowski K, Itzel T, Teufel A, Schuppan D, Stojanovic A, Cerwenka A, Nittka S, Piiper A, Gaiser T, Beraza N, Milkiewicz M, Milkiewicz P, Brain JG, Jones DEJ, Weiss TS, Zanger UM, Ebert M, Meindl-Beinker NM. Dropmann A, et al. Among authors: wosikowski k. Gut. 2020 Sep;69(9):1677-1690. doi: 10.1136/gutjnl-2019-319091. Epub 2020 Jan 28. Gut. 2020. PMID: 31992593 Free PMC article.
Preclinical antitumor activity of the oral platinum analog satraplatin.
Wosikowski K, Lamphere L, Unteregger G, Jung V, Kaplan F, Xu JP, Rattel B, Caligiuri M. Wosikowski K, et al. Cancer Chemother Pharmacol. 2007 Sep;60(4):589-600. doi: 10.1007/s00280-007-0502-z. Epub 2007 May 31. Cancer Chemother Pharmacol. 2007. PMID: 17541592
First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery.
Pfeiffer N, Voykov B, Renieri G, Bell K, Richter P, Weigel M, Thieme H, Wilhelm B, Lorenz K, Feindor M, Wosikowski K, Janicot M, Päckert D, Römmich R, Mala C, Fettes P, Leo E. Pfeiffer N, et al. Among authors: wosikowski k. PLoS One. 2017 Nov 30;12(11):e0188899. doi: 10.1371/journal.pone.0188899. eCollection 2017. PLoS One. 2017. PMID: 29190672 Free PMC article. Clinical Trial.
TGF-ß isoforms in cancer: Immunohistochemical expression and Smad-pathway-activity-analysis in thirteen major tumor types with a critical appraisal of antibody specificity and immunohistochemistry assay validity.
Riemenschneider MJ, Hirblinger M, Vollmann-Zwerenz A, Hau P, Proescholdt MA, Jaschinski F, Rothhammer-Hampl T, Wosikowski K, Janicot M, Leo E. Riemenschneider MJ, et al. Among authors: wosikowski k. Oncotarget. 2015 Sep 29;6(29):26770-81. doi: 10.18632/oncotarget.5780. Oncotarget. 2015. PMID: 26450853 Free PMC article.
23 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page